| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Chimeric Therapeutics Limited (AU: CHM)
CHM Technical Analysis
5
| As on 24th Dec 2024 CHM STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CHMSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | 0.00 | 0.00 |
| Volume | 18305494 | 1 Year | -0.03 | -75.00 |
| 52 Week High 0.04 | 52 Week Low 0.01 | ||||
AU Australia Most Active Stocks
| SBM | 0.20 | -33.33% |
| SYA | 0.03 | 0.00% |
| HWK | 0.09 | % |
| BRN | 0.32 | 6.67% |
| TMG | 0.04 | 0.00% |
| CPH | 0.01 | 0.00% |
| CHM | 0.01 | 0.00% |
| Z1P | 0.46 | -11.54% |
| RED | 0.35 | 2.94% |
| FEL | 0.04 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| CHM Daily Charts |
CHM Intraday Charts |
Whats New @ Bazaartrend |
CHM Free Analysis |
|
|
CHM Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
CHM Forecast December 2024
| 4th UP Forecast | 0.03 |
| 3rd UP Forecast | 0.02 |
| 2nd UP Forecast | 0.02 |
| 1st UP Forecast | 0.02 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -0 |
| 4th DOWN Forecast | -0.01 |
CHM Weekly Forecast
| 4th UP Forecast | 0.01 |
| 3rd UP Forecast | 0.01 |
| 2nd UP Forecast | 0.01 |
| 1st UP Forecast | 0.01 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | 0.01 |
CHM Forecast2024
| 4th UP Forecast | 0.09 |
| 3rd UP Forecast | 0.06 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.07 |
Chimeric Therapeutics Limited ( AU Australia Symbol : CHM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CHM Business Profile
Chimeric Therapeutics Limited researches, develops, and commercializes cell therapies for cancer in Australia. The company develops CLTX CAR T cell therapy that is in Phase I clinical study for Glioblastoma; and CDH17 CAR T, which is in preclinical study for neuroendocrine tumours, as well as colorectal, pancreatic, and gastric cancer. It has a strategic partnership with OncoBay Clinical for the development program of CLTX CAR T. The company was incorporated in 2020 and is based in Carlton, Australia. Address: 62 Lygon Street, Carlton, VIC, Australia, 3053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service